BridgeBio Pharma BBIO Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: BridgeBio Pharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BridgeBio Pharma's change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BridgeBio Pharma's change in inventories?
- BridgeBio Pharma (BBIO) reported change in inventories of $7.05M in Q1 2026.
- How has BridgeBio Pharma's change in inventories changed year-over-year?
- BridgeBio Pharma's change in inventories increased by 120.9% year-over-year, from $3.19M to $7.05M.
- What does change in inventories mean?
- The change in the value of goods held in stock.
- How do you interpret change in inventories?
- An increase in inventory consumes cash, which may signal anticipation of higher demand or potential overstocking issues.
- How does change in inventories compare across companies?
- Critical for commercial-stage pharma companies; less relevant for early-stage R&D firms with minimal inventory.